ELCC 2016: CheckMate 171, phase 2 trial of nivolumab for advanced squamous cell non-small cell lung cancer

VJOncology has 824 videos Subscribe Here

Description: At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Enriqueta Felip, MD, PhD, from Vall d’Hebron Institute of Oncology, Barcelona, Spain, discusses CheckMate 171, a multicenter phase 2 trial of nivolumab, an anti-PD-1 monoclonal antibody, in patients with stage IIIB/IV squamous cell non-small cell lung cancer who have received at least one prior systemic treatment.
Shared By : VJOncology
Posted on : 04/27/16
Added : 3 years ago